Clonidine Patch
Product Images NDC 0378-0872

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Clonidine (NDC 0378-0872). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Clonidine Cross Section (017e8de4 474d 42cb B8ef A6b1577ae995 01)

An illustration diagram showing the layered structure of a Clonidine transdermal patch. The diagram labels four key layers from top to bottom: Protective Film, Backing, Solid Matrix Reservoir, Adhesive Formulation, and Slit Release Liner. It is noted as not to scale.*

FDA Label Image

Patient Instructions Figure 1 (017e8de4 474d 42cb B8ef A6b1577ae995 03)

An instructional diagram showing the application of a clonidine transdermal patch. It depicts the patch placement on the upper arm with labels pointing to the patch and an adhesive cover intended to be applied over the patch if needed.*

FDA Label Image

Patient Instructions Figure 2 (017e8de4 474d 42cb B8ef A6b1577ae995 04)

Clonidine transdermal system patch 0.1 mg/day packaging label by Mylan Pharmaceuticals Inc. The label indicates the patch provides programmed delivery of clonidine for one week. The package contains one patch and includes an adhesive cover for use if the patch becomes loose.*

FDA Label Image

Patient Instructions Figure 3 (017e8de4 474d 42cb B8ef A6b1577ae995 05)

Black-and-white line drawing showing two hands applying or holding a transdermal patch. The illustration demonstrates how to handle or prepare the patch, which could correspond to the clonidine transdermal patch product.*

FDA Label Image

Patient Instructions Figure 4 (017e8de4 474d 42cb B8ef A6b1577ae995 06)

An illustration showing hands peeling the backing off a rectangular transdermal patch before application on the skin. The image depicts the proper technique for handling a medication patch, such as the Clonidine transdermal patch.*

FDA Label Image

Patient Instructions Figure 5 (017e8de4 474d 42cb B8ef A6b1577ae995 07)

An instructional illustration showing the application of a Clonidine transdermal patch on the upper arm of a person. The image depicts a hand pressing the patch onto the skin, indicating the proper placement and adhesion technique for the patch.*

FDA Label Image

Patient Instructions Figure 6 (017e8de4 474d 42cb B8ef A6b1577ae995 08)

Clonidine transdermal patch packaging label from Mylan Pharmaceuticals Inc. The label features a warning stating the adhesive cover does not contain active medication and instructs to apply it over the patch if necessary. The image shows an adhesive cover and the patch itself with an oval shape.*

FDA Label Image

Image 01

Clonidine 0.1 mg/day transdermal system patch packaging label from Mylan Pharmaceuticals Inc. The label displays the proprietary and generic name Clonidine, the dosage strength 0.1 mg/day, and instructions that the patch delivers 0.1 mg clonidine per day for one week. Storage instructions, manufacturer details, and a barcode are also visible. The packaging is predominantly blue and white with red text highlights.*

FDA Label Image

Image 02

Clonidine 0.2 mg/day transdermal system patch packaging label by Mylan Pharmaceuticals Inc. The box shows product name, dosage strength, NDC number 0378-0872-99, and details for the transdermal system including contents of 4 systems and 4 adhesive covers. The label includes storage instructions and warnings for transdermal use only, with manufacturer information.*

FDA Label Image

Image 03

Packaging label for Clonidine Transdermal System USP 0.3 mg/day patch by Mylan Pharmaceuticals Inc. The label highlights the programmed delivery of 0.3 mg clonidine per day via transdermal system for one week. It includes storage instructions, manufacturer information, NDC 0378-0873-99, contents of 4 systems and adhesive covers, and warnings about keeping the drug out of reach of children.*

FDA Label Image

Image 04

Chemical structure of clonidine, showing its molecular framework with two chlorine atoms attached to a benzene ring and a fused imidazoline ring system.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.